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During the periimplantation period of pregnancy, pig blastocysts
undergo morphological changes and differentiation requiring
secretion and transport of nutrients (histotroph) into the uterine
lumen. Of these nutrients, glucose is converted to fructose, an
isomer of glucose, by conceptus trophectoderm. Although glucose
is an energy source for proliferation and growth of mammalian
cells, the role of fructose in uterine histotroph is unclear although
it is the most abundant hexose sugar in fetal blood and ﬂuids of
ungulate mammals (e.g., cows, sheep, and pigs). In this study, we
used porcine trophectoderm cells to determine that fructose in-
creased cell proliferation, as did glucose. Western blot analyses
of porcine trophectoderm cell extracts revealed that fructose in-
creased the abundance of phosphorylated-RPS6K, -EIF4EBP1, and
-RPS6 over basal levels within 30 min, and those levels remained
elevated to 120 min. Phosphorylation of both RPS6K and EIF4EBP1
proteins in response to fructose was inhibited by inhibitors of both
PI3K and MTOR. Further, when we investigated the inhibition of
glutamine-fructose-6-phosphate transaminase 1 (GFPT1) by aza-
serine (an inhibitor of GFPT1) and GFPT1 siRNA, we found that
MTOR-RPS6K and MTOR-EIF4EBP1 signaling in response to fruc-
tose is mediated via GFPT1 activation and the hexosamine path-
way. We further demonstrated that fructose stimulates the
production of hyaluronic acid via GFPT1 and the hexosamine bio-
synthesis pathway. Collectively, these results demonstrate critical
roles for fructose that are mediated via the hexosamine biosyn-
thesis pathway to stimulate MTOR cell signaling, proliferation of
porcine trophectoderm cells, and synthesis of hyaluronic acid, a sig-
niﬁcant glycosaminoglycan in the pregnant uterus.
trophoblast | glycosaminoglycans
Domestic livestock species are invaluable animal models usedextensively in research relevant to human and veterinary
reproductive medicine as well as basic biological and biomedical
sciences (1, 2). In particular, the ewe is an established animal
model for studies of intrauterine growth restriction during fetal
life that is a predisposition for the adult onset of metabolic
disease (3). Ewes have a protracted periimplantation period of
pregnancy, a relatively short period of gestation, and are well
suited for metabolic studies to assess temporal and cell-speciﬁc
changes in gene expression in response to various hormones,
growth factors, and nutrients that are relevant to human and
veterinary medicine and basic aspects of reproductive biology.
Although fructose clearly is the major hexose sugar in fetal blood
and fetal ﬂuids of ungulate species such as sheep and pigs, it is
largely ignored with respect to function because it is not me-
tabolized via the glycolytic pathway or the Krebs cycle as an
energy source. Here we provide evidence that fructose affects
multiple metabolic pathways critical to pregnancy and metabo-
lism in multiple organ systems.
Fructose is the most abundant hexose sugar in fetal ﬂuids of
ungulate mammals (4–6). Fructose also is present in human fetal
ﬂuids (7), but it is a relatively minor sugar compared with glucose
(8, 9). Fructose also is a minor sugar in fetal blood and fetal
ﬂuids of dog, cat, guinea pig, rabbit, rat, and ferret (9). In gen-
eral, high levels of fructose are found in fetal blood and fetal
ﬂuids of mammals having epitheliochorial and synepitheliocho-
rial placentas (9) that are used extensively as animal models for
intrauterine growth (1, 2, 10). The placentas of these mammals
contain little or no glycogen, i.e., less than 0.5% of that in the
fetus. In contrast, mammals with endotheliochorial and hemo-
chorial placentas (11) have fetuses in which glucose is converted
to glucose-6-PO4 that enters either the pentose phosphate path-
way or the glycolytic pathway to meet the metabolic demands of
the rapidly developing conceptus.
Studies of pregnant ewes have revealed that (i) injection of
glucose into ewes results in a rapid increase in glucose followed
by a protracted increase in fructose in fetal blood; (ii) injection
of glucose into the umbilical vein of the fetus increases glucose in
maternal blood and hyperfructosemia in the fetus, indicating that
glucose can move from conceptus vasculature to maternal blood,
whereas fructose derived from glucose is not transported into
maternal blood; (iii) the placenta is the site of conversion of
glucose to fructose; (iv) fructose is produced continuously by the
placenta independent of glucose concentration in maternal or
fetal blood; and (v) the ﬂux of glucose from the maternal to the
fetal circulation can be as much as 70 mg/min in ewes made hy-
perglycemic (6, 12–14). These results were conﬁrmed in studies
using radiolabeled glucose to demonstrate its conversion to radi-
olabeled fructose by the placenta of pigs (15).
The role of fructose remains unclear. Therefore, it has been
ignored in studies of metabolic pathways associated with me-
tabolism of hexose sugars, because glucose, but not fructose, is
metabolized via the glycolytic pathway (16–20). Nevertheless,
fructose can be used for synthesis of nucleic acids and generation
of reducing equivalents in the form of NADPH H+ in the fetal
pig (21) and in HeLa cells (22). However, it has been reported
that neither fructose nor glucose is metabolized via the pentose
phosphate pathway in the ovine placenta (23). Fructose and
glucose are equivalent as substrates for entering metabolic
pathways leading to synthesis of neutral lipids and phospholipids
in heart, liver, kidney, brain, and adipose tissue of fetal lambs,
refuting general statements that fructose is not metabolized in
fetal tissues of domestic animals (24). In adults rats the activities
of glucose-6-phosphate dehydrogenase, malic enzyme, and ace-
tyl-CoA carboxylase in liver are stimulated by glucose; this
stimulation increases lipogenesis (25), and fructose enters
adipocytes by both insulin-independent and insulin-insensitive
mechanisms (26).
Fructose is the primary sugar in blood, allantoic ﬂuid, and
amniotic ﬂuid of the fetal pig, but it decreases in allantoic ﬂuid as
glucose increases between days 82 and 112 of the 114-d period of
gestation (27). The rapid clearance of fructose from blood of
piglets by 24 h postpartum indicates that the neonatal piglet is
unable to use fructose as an energy source (28, 29).
Because of the lack of understanding of the role of fructose,
the most abundant hexose sugar in the pregnant uterus, we
conducted experiments to elucidate fructose metabolism using
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our established porcine trophectoderm (pTr) cell line. Our
results demonstrated that fructose is involved actively in stimu-
lating cell proliferation and mRNA translation via the activation
of mechanistic target of rapamycin (MTOR) cell signaling and
synthesis of glycosaminoglycans, speciﬁcally hyaluronic acid, via
the hexosamine metabolic pathway. Speciﬁcally, this study fo-
cused on MTOR complex 1 (MTORC1), which includes the
regulatory-associated protein of MTOR (Raptor), mammalian
LST8/G protein β-subunit–like protein (mLST8/GβL), and their
AKT1 substrate 1, proline-rich (AKT1S1) and disheveled, Egl-
10, and pleckstrin domain-containing protein 6 (DEPDC6) that
is involved with nutrient and energy sensing and protein synthesis
and is responsive to insulin, growth factors, serum, phosphatidic
acid, amino acids, and oxidative stress (30).
Results
Glucose and Fructose Stimulate pTr Cell Proliferation. We ﬁrst in-
vestigated biological effects of glucose and fructose on pro-
liferation of pTr cells. Treatment of pTr cells with glucose in
customized medium containing 5% serum for 48 h and 96 h
increased pTr cell numbers by 1.8- fold (P < 0.01) and 3.2-fold
(P < 0.01), respectively (Fig. 1A). Similarly, at 48 h and 96 h of
fructose treatment, pTr cell numbers increased by 2.7-fold (P <
0.01) and 5.3-fold (P < 0.01), respectively (Fig. 1B). However,
there was no evidence that treatment of pTr cells with both
glucose and fructose had either additive or synergistic effects
(P > 0.10) (Fig. 1C). These results indicate that fructose and
glucose stimulate pTr cell proliferation, but the fold-increase was
greater for fructose.
Glucose and Fructose Activate MTOR Signaling in pTr Cells. The pTr
cells deprived of glucose and fructose for 6 h after serum starva-
tion were treated with 4 mM glucose or 4 mM fructose. Western
blot analyses of whole pTr cell extracts indicated that glucose
increased phosphorylated ribosomal protein S6K (p-RPS6K),
p-eukaryotic translation initiation factor 4E-binding protein 1
(p-EIF4EBP1), and p-ribosomal protein S6 (p-RPS6) by 2.7-fold
(P< 0.01), 2.4-fold (P< 0.01), and 6.1-fold (P< 0.01), respectively,
over basal levels within 30 min and that this level of activation was
maintained to 120 min after treatment (Fig. 2 A–C). Likewise,
fructose increased the abundance of p-RPS6K, p-EIF4EBP1, and
p-RPS6 by 2.9-fold (P < 0.01), 2.3-fold (P < 0.01), and 4.2-fold
(P < 0.01), respectively, over basal levels within 30 min, and this
level of activation was maintained to 120 min after treatment (Fig.
2 D–F). These results indicate that both fructose and glucose ac-
tivate theMTOR-RPS6K–RPS6 orMTOR–EIF4EBP1 pathways,
stimulating proliferation and growth of pTr cells.
We next performed immunoﬂuorescence analyses to deter-
mine cellular locations of p-RPS6K, p-EIF4EBP1, and p-RPS6
in response to treatment of pTr cells with 4 mM glucose or 4 mM
fructose. The abundance of p-RPS6K protein increased in the
nucleus after treatment with glucose and fructose but not in
untreated pTr cells (Fig. 3A). The p-EIF4EBP1 protein was lo-
calized predominantly in the nucleus but also, to a much lesser
extent, was found in the cytoplasm of pTr cells in response to
glucose and fructose (Fig. 3B). The p-RPS6 protein was abun-
dant in the cytoplasm of pTr cells treated with glucose and
fructose (Fig. 3C). These results indicate that each effector
protein involved in mRNA translation downstream of MTOR
Fig. 1. Dose-dependent effects of glucose (A), fructose (B), and glucose plus fructose (C) on the proliferation of pTr cells. The pTr cells were seeded at 30%
conﬂuence in wells and cultured with the indicated doses of glucose and fructose. Cell numbers were determined after 48 h (Left) or 96 h (Right) of in-
cubation, and data are expressed as a percentage relative to nontreated control (100%). All quantitative data are presented as the LSM with overall SEM. See
Materials and Methods for a complete description.
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was localized in and presumably exerted its functional role in
different intracellular compartments of pTr cells to stimulate
cell proliferation.
MTOR Signal Transduction Induced in pTr Cells by Glucose and
Fructose Involves PI3K/AKT1 Proteins. To determine the cell-sig-
naling pathways mediating effects glucose and fructose on PI3K/
Fig. 2. Analysis of time-dependent phosphorylation of RPS6K (A and D), EIF4EBP1 (B and E), and RPS6 (C and F) in response to glucose (A, B, and C) and
fructose (D, E, and F) in pTr cells at 0, 15, 30, 60, and 120 min after treatment. Monolayers of 80% conﬂuent pTr cells were serum starved for 24 h, then
deprived of either glucose or fructose for 6 h, and then treated with physiological concentrations of glucose (4 mM) or fructose (4 mM). Blots were imaged to
calculate the normalized values as levels of phosphorylated protein relative to total protein. See Materials and Methods for a complete description.
Fig. 3. Immunoﬂuorescence localization of p-RPS6K (A), p-EIF4EBP1 (B), and p-RPS6 (C) proteins in pTr cells. Immunoreactive p-RPS6K protein was localized
predominantly in the nucleus of pTr cells treated with glucose or fructose, p-EIF4EBP1 protein was localized in the cytoplasm and nucleus of pTr cells treated
with glucose and fructose, respectively; p-RPS6 protein was localized primarily in the cytoplasm of pTr cells treated with glucose or fructose. (Magniﬁcation:
40×.). See Materials and Methods for a complete description.
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AKT1, RPS6K, and EIF4EBP1, pTr cells were pretreated with
pharmacological inhibitors of either PI3K (25 μM LY294002) or
MTOR kinase (25 nM rapamycin) for 2 h. Results indicated that
phosphorylation of both RPS6K and EIF4EBP1 in response to
glucose was inhibited by both PI3K and MTOR inhibitors (P <
0.01 or P < 0.001, respectively; Fig. 4 A and C). Likewise, in-
duction of phosphorylation of both RPS6K and EIF4EBP1 by
fructose was inhibited by both PI3K and MTOR inhibitors (P <
0.01 or P < 0.001, respectively; Fig. 4 B and D). These results
suggest that activation of the PI3K–AKT1 pathway by fructose is
required for transcriptional activation in the fructose-induced
cell signaling cascade from cytoplasm to nucleus to enhance
proliferation and growth of pTr cells.
MTOR Cell Signaling in Response to Glucose and Fructose Is Mediated
by Glutamine-Fructose-6-Phosphate Transaminase 1 Activity. To ex-
amine whether glutamine-fructose-6-phosphate transaminase 1
(GFPT1) is both an upstream effector of MTOR and a nutrient
sensor in the hexosamine biosynthesis pathway, we used aza-
serine (an inhibitor of GFPT1) to assess whether GFPT1 activity
is required for glucose and fructose to activate pTr cell pro-
liferation. Azaserine inhibited (P < 0.01) the ability of both
glucose (Fig. 5A) and fructose (Fig. 5B) to stimulate pro-
liferation of pTr cells. In particular, the rate of pTr cell pro-
liferation decreased 70–80% with the addition of 1 μM azaserine
compared with effects of glucose alone (Fig. 5A) or fructose
alone (Fig. 5B). Even in the presence of both fructose and glu-
cose, azaserine inhibited (P < 0.01) proliferation of pTr cells
(Fig. 5C). These results indicate that the nutrient-sensing system
in pTr cells is more sensitive to fructose than to glucose.
The next experiment used Western blot analyses of whole pTr
cell extracts treated with azaserine to determine if inhibition of
GFPT1 decreased the abundance of p-RPS6K and p-EIF4EBP1
proteins (Fig. 6 A and B). Interestingly, the phosphorylation of
RPS6K and EIF4EBP1 proteins was inhibited more by treatment
with the combination of azaserine and LY294002 than by
treatment with azaserine alone when pTr cells were stimulated
with either glucose or fructose (Fig. 6 C and D). These results
suggest that fructose stimulation of the MTOR signaling cascade
is affected by both the AKT1- and GFPT1-dependent cell-sig-
naling pathways for stimulation of proliferation and growth of
pTr cells.
The next step was to perform a GFPT1-knockdown experiment
using GFPT1-speciﬁc siRNAs. As illustrated in Fig. 7A, GFPT1
protein expression was inhibited by 70, 80, and 81% 48 h after
transfection with GFPT1 siRNA at 10, 25, and 50 nM, respec-
tively. Cells transfected with the GFPT1-speciﬁc siRNA had less
GFPT1 than did naive and mock-treated cells (P < 0.001) or cells
transfected with control siRNA (P < 0.001). To verify these
results, we performed immunoﬂuorescence analyses and com-
pared the expression patterns of GFPT1 protein in pTr cells
cultured in the presence of control and GFPT1 siRNA (Fig. 7B).
Immunoreactive GFPT1 protein was most abundant in the nu-
cleus of pTr cells treated with control siRNA and naive cells but
was barely detectable in cells transfected with GFPT1 siRNA.
When combined with GFPT1 siRNA, glucose inhibited pTr cell
proliferation by 60%, and fructose inhibited pTr cell proliferation
by 72% (P < 0.01). Also, when both fructose and glucose plus
GFPT1 siRNA were used to culture pTr cells, cell proliferation
decreased by about 50% (P < 0.01) (Fig. 7 C–E). Collectively,
these results demonstrate that stimulation of the MTOR–RPS6K
and MTOR–EIF4EBP1 signaling pathways by glucose and fruc-
tose is mediated through GFPT1 and the hexosamine pathway.
Glucose and Fructose Stimulate Hyaluronic Acid Synthesis. Hyalur-
onic acid, a glycosaminoglycan synthesized via the hexosamine
biosynthesis pathway, may play an essential role in angiogenesis
and other aspects of cell function, particularly in the placenta
during early pregnancy (31). Therefore, we determined whether
fructose stimulates hyaluronic acid synthesis. As illustrated in Fig.
8A, glucose increased the amount of secreted hyaluronic acid by
6.2-fold at 48 h and by 11.3-fold at 96 h, and this effect was inhibited
by azaserine in a dose-dependent manner. Pericellular hyaluronic
acid also was increased by glucose treatment and inhibited by
azaserine. Similarly, fructose increased secreted hyaluronic acid by
10.5- and 12.0-fold (P < 0.01) and increased pericellular hyaluronic
acid by 7.0- and 7.3-fold (P < 0.01) at 48 h and 96 h of culture,
respectively, and the effects of fructose were inhibited by azaserine
in a dose-dependent manner (Fig. 8B). These results indicate that
fructose and glucose stimulate the production of hyaluronic acid
via GFPT1 and the hexosamine biosynthesis pathway to stimulate
growth and development of the porcine trophoblast and perhaps
the embryo/fetus during pregnancy.
Discussion
This study provides evidence for key roles of fructose in cellular
functions and detailed analyses of the actions of fructose on cell-
signaling pathways affecting proliferation and mRNA translation
of cells (in this case, pTr cells). The results support our hy-
pothesis that fructose is metabolized to glucosamine-6-PO4 by
GFPT1 of the hexosamine biosynthesis pathway and stimulates
the MTOR cell-signaling pathway to increase proliferation and
mRNA translation of porcine conceptus trophectoderm cells.
Researchers focusing on intrauterine growth restriction and
on the subsequent adult onset of metabolic disease in various
ungulate species have ignored fructose as an important meta-
bolic substrate, perhaps because fructose is not metabolized via
the glycolytic pathway in the placenta, fetus, or neonate (16–20).
Fig. 4. Inhibition of RPS6K (A and B) and EIF4EBP1 (C and D) phosphory-
lation. Monolayers of 80% conﬂuent pTr cells were serum starved for 24 h,
deprived of glucose and fructose for 6 h, and then pretreated with 25 μM
LY294002 or 25 nM rapamycin for 30 min. After stimulation with 4 mM
glucose (A and C) or 4 mM fructose (B and D) for 60 min, total cell lysates
were subjected to SDS/PAGE followed by Western blotting. Both rapamycin
and LY294002 inhibited increases in p-RPS6K and p-EIF4EBP1. Blots were
imaged to calculate the normalized values presented as levels of phos-
phorylated protein relative to total protein. Asterisks denote an effect
of treatment (*P < 0.01; **P < 0.001). All quantitative data are presented
as the LSM with overall SEM. See Materials and Methods for a complete
description.
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In ewes, for example, the maximum concentration of glucose in
allantoic ﬂuid is 1.1 mM between days 35 and 140 of pregnancy,
whereas the concentration of fructose is between 11.1 and 33
mM during the same period (32). Therefore, in accordance with
the results shown in Fig. 1, fructose exerts its maximum effects
on cell proliferation at molar concentrations well below those in
allantoic ﬂuid. Glucose, on the other hand, was tested at physi-
ological concentrations and at concentrations above those found
in allantoic ﬂuid. Therefore, fructose is the hexose sugar most
likely to stimulate the MTOR nutrient-sensing pathway and to be
metabolized via the hexosamine pathway to stimulate growth and
development of the conceptus.
Fructose also is the primary sugar in blood, allantoic ﬂuid, and
amniotic ﬂuid of the fetal pig; it increases in allantoic ﬂuid until
day 80 of gestation and then decreases as glucose increases be-
tween days 82 and 112 of pregnancy (27). Fructose is cleared
rapidly from blood of newborn piglets, falling to almost un-
detectable levels by 24 h postpartum (27). Further, the neonatal
piglet is unable to use fructose as an energy source (27, 28).
The present study revealed that the stimulatory effect of
fructose on pTr cell proliferation is equivalent to or greater
than that of glucose. These results explain the role of fructose
[which has been called “the most enigmatic aspect of embryonic
carbohydrate metabolism” (7)] in the development of the con-
ceptus (embryo/fetus and its associated placenta). Furthermore,
we found that fructose induces phosphorylation of RPS6K,
RPS6, and EIF4EBP1 in pTr cells. In general, MTOR–RPS6K
cell signaling relays signals stimulated by nutrients such as amino
acids and mitogens to stimulate cell proliferation, differentiation,
and gene expression (33). MTOR also acts in parallel with the
Fig. 5. Inhibition of GFPT1 activity. pTr cells pretreated for 2 h with the indicated doses of azaserine were stimulated with 4 mM glucose (A), 4 mM fructose
(B), or 4 mM glucose and 5 mM fructose (C) or for 96 h. The cell-culture mediumwas changed every 48 h. Cell numbers were determined after stimulation, and
data are expressed as a percentage relative to nontreated control (100%). Asterisks denote an effect of treatment (*P < 0.01). All quantitative data are
presented as the LSM with overall SEM. See Materials and Methods for a complete description.
Fig. 6. Inhibition of GFPT1 decreased the abundance of RPS6K and EIF4EBP1 phosphorylation. Monolayers of 80% conﬂuent pTr cells were serum starved for
24 h, deprived of glucose and fructose for 6 h, and then were pretreated with 25 μM LY294002 or 25 nM rapamycin for 30 min and azaserine for 2 h to inhibit
PI3K, MTOR, and GFPT1, respectively. Panels A and B indicate effects of inhibitors of PI3K, MTOR, and GFPT1 in p-RPS6K. Panels C and D indicate effects of the
same respective inhibitors on p-EIF4EBP1. After stimulation, total cell lysates were subjected to SDS/PAGE followed by Western blotting. Blots were imaged to
calculate the normalized values presented as levels of phosphorylated protein relative to total protein. Asterisks denote an effect of treatment (*P < 0.01;
**P < 0.001). All quantitative data are presented as the LSM with overall SEM. See Materials and Methods for a complete description.
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PI3K–AKT1 pathway to transduce growth factor signals and
regulate common downstream effectors such as RPS6K and
EIF4EBP1. However, little is known about the roles of the
members of MTOR–RPS6K or PI3K–AKT pathways in pTr
development during early pregnancy. The present study dem-
onstrates that fructose and glucose activate RPS6K, RPS6,
and EIF4EBP1 and that LY294002 and rapamycin inhibit that
activation. Thus, fructose likely inﬂuences porcine fetal/placental
development by activating the MTOR–RPS6K and/or PI3K–
AKT pathways during the periimplantation period of conceptus
development.
In the present study, stimulation of the MTOR cell-signaling
pathway by glucose and fructose was mediated via GFPT1 and
the hexosamine pathway. As a nutrient sensor in the hexosamine
biosynthesis pathway and an MTOR upstream effector, fructose-
mediated GFPT1 activity was inhibited by azaserine, which
decreased pTr cell proliferation and levels of p-RPS6K and
p-EIF4EBP1 proteins in pTr cells. In addition, with respect to
effects mediated by either glucose or fructose, the phosphory-
lation of RPS6K and EIF4EBP1 proteins was inhibited more by
the combination of azaserine plus LY294022 than by the com-
bination of azaserine plus LY294002 and rapamycin. Therefore,
we suggest that fructose stimulates both MTOR–RPS6K and
MTOR–EIF4EBP1 signaling cascades for trophoblast cell
growth. Other metabolic pathways for activation by fructose re-
main to be explored to elucidate its role in the pregnant uterus
and in other organ systems.
The pentose phosphate pathway is responsible for the gener-
ation of reducing equivalents, in the form of NADPH, used in
reductive biosynthesis reactions within cells (e.g., fatty acid syn-
thesis), production of ribose-5-phosphate used in the synthesis of
nucleotides and nucleic acids, and production of erythrose-4-
phosphate used in the synthesis of tyrosine, citrulline, and pro-
line. There is evidence that fructose is used for the synthesis of
nucleic acids and reducing equivalents in the form of NADPH
H+ in the fetal pig (21), in ovine placenta (22), and in HeLa cells
cultured with fructose as the only hexose sugar (23).
Fructose and glucose are equivalent as substrates in entering
metabolic pathways leading to synthesis of neutral lipids and
phospholipids in the heart, liver, kidney, brain, and adipose
tissue of fetal lambs, refuting general statements that fructose
in not metabolized in fetal tissues of domestic animals (24). In
adult rats the hepatic activities of glucose-6-phosphate de-
hydrogenase, malic enzyme, and acetyl-CoA carboxylase are
stimulated by glucose, which increases lipogenesis (25), and
fructose enters adipocytes by both insulin-independent and in-
Fig. 7. GFPT1 knockdown decreased proliferation of pTr cells. (A) GFPT1 protein levels were measured in the control group (naive, mock, and control siRNA
treatment) and in the GFPT1-silenced group (GFPT1 siRNA) in a dose-dependent manner. Blots were imaged to calculate the normalized values presented as
levels of GFPT1 protein relative to TUBA protein. (B) Immunoﬂuorescence microscopy detected GFPT1 protein in naive and control siRNA treatments but not
in the GFPT1-silenced group. (C–E) Effects of glucose (C), fructose (D), and fructose plus glucose (E) combined with GFPT1 siRNA treatment on proliferation of
pTr cells. Asterisks denote an effect of treatment (*P < 0.01). All quantitative data are presented as the LSM with overall SEM. SeeMaterials and Methods for
a complete description.
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sulin-insensitive mechanisms (26). In studies with HeLa cells in
medium containing 1 mM glucose or less, 80% of the glucose is
metabolized via glycolysis, but only 4–5% of the glucose enters
the tricarboxylic acid (TCA) cycle. When 2 mM fructose was
present in the medium, about 100 times fewer molecules of
fructose than glucose were used per mass of cells, and glycolytic
activity was reduced about 900-fold. Almost all fructose entered
the pentose shunt to produce reducing equivalents and nucleic
acids necessary for biosynthetic processes. With fructose in the
medium, HeLa cells used glutamine to provide about 98% of
the energy, but fructose had no effect on intracellular levels of
ATP or TCA-cycle intermediates.
It is possible that the developing conceptus uses fructose in a
manner similar to that used by HeLa cells. That is, fructose may be
metabolized via the oxidative arm of the pentose shunt to provide
the necessary substrate for high rates of cell proliferation and as-
sociated biosynthetic processes. Energy may be derived from glu-
tamine catabolism, and it is important to note that glutamine is
required for conversion of fructose-6-PO4 to glucosamine-6-PO4
(34). A study to determine amino acid concentrations in ovine
allantoic ﬂuid and amniotic ﬂuid, as well as in fetal and maternal
plasma in pregnant ewes between days 30 and 140 of gestation,
revealed that alanine, glutamine, glycine, and serine contributed
50% of total α-amino acids in fetal plasma (35). Interestingly,
Fig. 8. Glucose and fructose stimulate hyaluronic acid (HA) synthesis and secretion in porcine trophectoderm cells. pTr cells were serum starved for 24 h and
pretreated with different concentrations of azaserine for 2 h and then were treated or not treated with glucose (A) or fructose (B) for 48 h (Left) or 96 h
(Right). (A) Quantitation of secreted (Upper) and pericellular (Lower) hyaluronic acid by glucose. (B) Quantitation of secreted (Upper) and pericellular (Right)
hyaluronic acid by fructose. The amount of secreted and pericellular hyaluronic acid in each extract was measured by ELISA based on the speciﬁc interaction
of hyaluronic acid with hyaluronic acid-binding protein. Asterisks denote an effect of treatment (*P < 0.01). See Materials and Methods for a complete
description.
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concentrations of alanine, citrulline, and glutamine in allantoic
ﬂuid increased 20-, 34-, and 18-fold, respectively, between days 30
and 60 of gestation and were 24.7, 9.7, and 23.5 mM, respectively,
during this period of rapid placental growth and development (32,
35). Remarkably, in sheep, alanine, citrulline, and glutamine
accounted for∼80% of total α-amino acids in allantoic ﬂuid during
early gestation, when both the concentration and total amount of
fructose increase rapidly (35).
Unique features of fructose may be its production by the
placenta and its sequestration in fetal blood and fetal ﬂuids to be
metabolized along with glutamine via the hexosamine pathway.
This pathway leads to synthesis of glycosaminoglycans, e.g.,
hyaluronic acid, uridine diphosphate-N-acetyl glucosamine, and
uridine diphosphate-N-acetyl galactosamine, that are involved in
the synthesis of glycolipids, glycosaminoglycans, and proteogly-
cans critical to cell and tissue functions. Hyaluronic acid and
hyaluronidase increase in the uterine lumen of pigs in response
to progesterone (36). This may stimulate angiogenesis (31) and/
or morphogenesis and tissue remodeling of the placenta as
reported for the human placenta (37). Wharton’s jelly, which is
composed primarily of hyaluronic acid and also supports ﬁbro-
blasts and stem cells (38), accumulates in the placentas of most
mammals and localizes primarily in the umbilical cord but also,
to a lesser extent, in placental blood vessels (39). It is clear that
angiogenesis is critical to conceptus development in all species,
and results of the present study indicate that fructose is used for
synthesis of glycosaminoglycans such as hyaluronic acid that
support angiogenesis, particularly in the placenta.
Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) is
involved extensively in intracellular signaling as a substrate for
O-linked N-acetylglucosamine transferases, nuclear pore forma-
tion and nuclear signaling, and the glucose-sensing mechanism, as
well as for cellular insulin sensitivity (40). Uridine diphosphate-N-
acetylgalactosamine is another sugar-donor metabolite; its addi-
tion to serine or threonine residues represents the ﬁrst step in the
biosynthesis of mucins such as O-glycans that impart unique
structural features to mucin glycoproteins and membrane re-
ceptors and resistance to thermal change and proteolytic attack to
a number of proteins. The O-linked carbohydrate side chains
function as ligands for receptors for lymphocyte and leukocyte
homing and as signals for protein sorting. Overactivity of the
hexosamine pathway results in increased UDP-hexosamines; this
increase is an important mechanism by which hyperglycemia
causes insulin resistance.
Glucose was reported to induce proliferation of human tro-
phoblast cells through MTOR signaling in a PI3K-independent
mechanism that involves activation of MTOR by metabolites of
the GFPT1 pathway, particularly UDP-GlcNAc: (41). They pro-
posed that UDP-GlcNAc is responsible for phosphorylation of
TSC2, a GTPase-activating protein, and p70S6K1, a protein ki-
nase downstream of MTOR, to stimulate trophoblast cell pro-
liferation in response to the metabolism of glucose to glucose-6-
PO4, fructose-6-PO4, and glucosamine-6-PO4. Results from the
present study indicate that fructose can stimulate theMTOR cell-
signaling pathway to affect cell proliferation and also can be used
in the hexosamine pathway to synthesize hyaluronic acid that can
affect angiogenesis and other aspects of fetal/placental develop-
ment during pregnancy (Fig. 9).
In summary, the placenta converts available glucose from the
mother to fructose, which is sequestered in blood and ﬂuids (al-
lantoic and amniotic) of the conceptus. The literature indicates
that fructose enters cells and is converted to fructose-1-PO4, but it
also may be converted to fructose-6-PO4, which then can be
metabolized by various tissues of the conceptus via either the
pentose phosphate pathway or the hexosamine pathway. In the
mammalian conceptus, fructose plays a role in activating MTOR
cell signaling via the hexosamine-synthetic pathway, thereby
promoting embryonic/fetal growth and development. Thus, the
unusual abundance of fructose in fetal blood and fetal ﬂuids has
a physiological role during gestation that must be taken into ac-
count in studies of intrauterine development of the conceptus.
Materials and Methods
Cell Culture. An established mononuclear pTr cell line from day 12 pig con-
ceptuses was used in the present in vitro studies, as described previously
(42,43). For each experiment, the design was replicated in three indepen-
dent experiments.
Proliferation Assay. The pTr cells (20% conﬂuent) were subcultured in 24-well
plates in growth medium until the monolayer reached up to 30% conﬂuence
and thenwere switched to serum- and insulin-free customizedmedium. After
starvation for 24 h, cells were deprived of glucose and fructose for 6 h. Then
either glucose or fructose was added to each well (n = 3 wells per treatment)
with 5% (vol/vol) serum at the indicated concentration. Cells grown in se-
rum-free specialized medium and specialized medium containing 10% FBS
served as negative and positive controls, respectively. Cell numbers were
determined as described previously (44–48).
Western Blot Analyses. Whole-cell extracts and immunoblot assays were
prepared and performed as described previously (44). Immunoreactive pro-
teins were detected using rabbit anti-human polyclonal antibodies against
p-RPS6 IgG at a 1:1,000 dilution and RPS6 IgG at a 1:2,000 dilution and 10%
(wt/wt) SDS/PAGE gel; rabbit anti-human polyclonal p-RPS6K IgG at a 1:1,000
dilution and RPS6K IgG at a 1:2,000 dilution and 10% SDS/PAGE gel; and
rabbit anti-human polyclonal p-EIF4EBP1 IgG and EIF4EBP1 IgG, each at
a 1:1,000 dilution, and 15% (wt/wt) SDS/PAGE gel. As a loading control,
mouse anti–α-tubulin (TUBA) IgG was used after the proteins were detected
on the Western blots. All antibodies were from Cell Signaling Technology.
Multiple exposures of each Western blot were performed to ensure line-
arity of chemiluminescent signals.
Immunoﬂuorescence Analyses. The effects of glucose and fructose on phos-
phorylation of RPS6K, EIF4EBP1, and RPS6 were determined by immuno-
ﬂuorescence microscopy as previously described (44, 45). Cells probed with
rabbit anti-human polyclonal p-RPS6K IgG (Thr421/Ser424) at a 1:200 di-
Fig. 9. Schematic diagram of the GFPT1-mediated MTOR cell-signaling
pathway affected by glucose and fructose in pTr cells. Fructose stimulates
GFPT1 in the hexosamine biosynthesis pathway and activates MOTR–RPS6K
and MTOR–EIF4EBP1 signal transduction cascades for stimulation of pTr cell
proliferation and growth. AKT1, proto-oncogenic protein kinase Akt;
EIF4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; Fru,
fructose; Fru-1P, fructose-6-phosphate (fructose-6P); GlcN-6P, N-acetylglu-
cosamine-6-phosphate; GFPT1, glutamine-fructose-6-phosphate transami-
nase 1; Glc, glucose; Glc-6P, glucose-6-phosphate; GLUT, glucose/fructose
transporter; MTOR, mechanistic target of rapamycin; RPS6, ribosomal pro-
tein S6; RPS6K, ribosomal protein S6K; TSC2, tuberous sclerosis 2; UDP-
GlcNAC, UDP-N-acetylglucosamine.
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lution, rabbit anti-human polyclonal p-RPS6 IgG at a 1:200 dilution, or rabbit
anti-rat polyclonal p-EIF4EBP1 IgG at a 1:200 dilution (antibodies were from
Cell Signaling Technology) were incubated with goat anti-rabbit IgG Alexa
488 (Chemicon) at a 1:200 dilution for 1 h at room temperature. Cells then
were washed and overlaid with Prolong Gold Antifade with DAPI. For each
primary antibody, images were captured with identical microscope and
detector settings to facilitate comparisons of spatial distribution and ﬂuo-
rescence intensity among treatments.
Target-Speciﬁc siRNAs for GFPT1 Knockdown. For mRNA sequences of porcine
GFPT1 (NM_001194979.1), three potential siRNA target sites were deter-
mined using the Invitrogen design program. The most effective target se-
quence (CAG AUC AUG AAG GGC AAC U) was selected and synthesized.
Silencer Negative Control siRNA (Cell Signaling Technology), which does not
cause speciﬁc degradation of any cellular mRNA, was used as a negative
control. Down-regulation of GFPT1 expression was conﬁrmed by Western
blotting analyses and immunoﬂuorescence.
Transfection. The pTr cells were treated with speciﬁc GFPT1 siRNA; controls
included cells that received naive treatment (no siRNA or Lipofectamine 2000)
or mock treatment (Lipofectamine 2000 only). Transfection of siRNA was
performed according to the manufacturer’s procedure. To analyze the
effects of azaserine on glucose- and fructose-induced proliferation in pTr
cells, glucose (4 mM) and/or fructose (4 mM) with azaserine was added to
the culture medium 48 h after transfection, and the incubation was con-
tinued for another 48 h. Using green ﬂuorescein conjugate control siRNA
duplexes (Cell Signaling Technology), we estimated that more than 95% of
the cells were transfected successfully.
Quantitation of Hyaluronic Acid. The amount of hyaluronic acid was measured
as described previously (37), with minor modiﬁcations. After treatment, cell
culture medium was centrifuged at 8,000 × g at 4 °C for 5 min, and the
supernatant was assayed to determine secreted hyaluronic acid. Then cells
were washed three times with PBS and treated with Trypsin-EDTA (0.25%)
solution at 37 °C for 5 min; the reaction was stopped by the addition of
culture medium just before cell numbers were determined by using a he-
mocytometer. The cells then were centrifuged, and the supernatant was
used for quantitation of pericellular hyaluronic acid. The cell pellet was
digested with proteinase K (120 μg/mL) and centrifuged, and the superna-
tant was analyzed for intracellular hyaluronic acid. The amount of hyalur-
onic acid in each different extract was measured by ELISA based on the
speciﬁc interaction of hyaluronic acid with hyaluronic acid-binding protein
as determined using the hyaluronic acid detection kit (R&D Systems). To
serve as the negative control, some samples were pretreated with hyal-
uronidase (2 units/mL at 37 °C for 2 h) before being subjected to the ELISA.
Statistical Analyses. All quantitative data were subjected to least-squares
ANOVA using the general linear models procedures of the Statistical Analysis
System (SAS Institute, Inc.). Percent changes in responses were analyzed
following log transformation, because percentages are not distributed
normally. Data from Western blotting were corrected for differences in
sample loading using TUBA data as a covariate. All tests of signiﬁcance were
performed using the appropriate error terms according to the expectation of
the mean squares for error. Signiﬁcance was considered to be P ≤ 0.05. Data
are presented as the least-squares mean (LSM) and SEM.
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